Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring

被引:120
|
作者
Andrs, Martin [1 ,2 ]
Korabecny, Jan [1 ]
Jun, Daniel [1 ,2 ]
Hodny, Zdenek [3 ]
Bartek, Jiri [3 ,4 ]
Kuca, Kamil [1 ]
机构
[1] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove 50005, Czech Republic
[2] Univ Def, Fac Mil Hlth Sci, Dept Toxicol & Mil Pharm, Hradec Kralove 50001, Czech Republic
[3] ASCR, Vvi, Inst Mol Genet, Dept Genome Integr, Prague 14220, Czech Republic
[4] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark
关键词
DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; TARGETING DNA-REPAIR; IN-VIVO EVALUATION; MAMMALIAN TARGET; ATAXIA-TELANGIECTASIA; (PI3K)/MAMMALIAN TARGET; PI3K/AKT/MTOR PATHWAY; BIOLOGICAL EVALUATION; SELECTIVE INHIBITOR;
D O I
10.1021/jm501026z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Phosphatidylinositol 3-kinases (PI3Ks) and phosphatidylinositol 3-kinase-related protein kinases (PIKKs) are two related families of kinases that play key roles in regulation of cell proliferation, metabolism, migration, survival, and responses to diverse stresses including DNA damage. To design novel efficient strategies for treatment of cancer and other diseases, these kinases have been extensively studied. Despite their different nature, these two kinase families have related origin and share very similar kinase domains. Therefore, chemical inhibitors of these kinases usually carry analogous structural motifs. The most common feature of these inhibitors is a critical hydrogen bond to morpholine oxygen, initially present in the early nonspecific PI3K and PIKK inhibitor 3 (LY294002), which served as a valuable chemical tool for development of many additional PI3K and PIKK inhibitors. While several PI3K pathway inhibitors have recently shown promising clinical responses, inhibitors of the DNA damage-related PIKKs remain thus far largely in preclinical development.
引用
收藏
页码:41 / 71
页数:31
相关论文
共 50 条
  • [31] Computational Design of Phosphatidylinositol 3-Kinase Inhibitors
    Rani, Isha
    Goyal, Anju
    Sharma, M.
    [J]. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2022, 20 (07) : 317 - 337
  • [32] Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal
    Pereira, Alban R.
    Strangman, Wendy K.
    Marion, Frederic
    Feldberg, Larry
    Roll, Deborah
    Mallon, Robert
    Hollander, Irwin
    Andersen, Raymond J.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (24) : 8523 - 8533
  • [33] Impact of the phosphatidylinositol 3-kinase (PI3K) pathway on cytokine generation by human neutrophils
    Fortin, Carl F.
    McDonald, Patrick P.
    [J]. CYTOKINE, 2009, 48 (1-2) : 82 - 83
  • [34] Inhibition of phosphatidylinositol 3-kinase (PI3K) improves contractility in α-adrenergic stimulated myocardium
    Jacobshagen, Claudius
    Kortlepel, Swantje
    Unsoeld, Bernhard W.
    Kogler, Harald
    Hasenfuss, Gerd
    Maier, Lars S.
    [J]. CIRCULATION, 2007, 116 (16) : 290 - 291
  • [35] The role of the phosphatidylinositol 3-kinase (PI3K) pathway in the development and treatment of uterine cancer
    Naumann, R. Wendel
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 411 - 420
  • [36] Phosphatidylinositol 3-Kinase (PI3K) Pathway Activation in Breast Cancer Brain Metastases
    Anders, C. K.
    Adamo, B.
    Deal, A. M.
    Livasy, C. A.
    Meng, H.
    Burrows, E.
    Fritchie, K.
    Blackwell, K. L.
    Geradts, J.
    Ewend, M. G.
    Carey, L. A.
    Miller, R.
    [J]. CANCER RESEARCH, 2010, 70
  • [37] Development of a novel PET tracer targeting phosphatidylinositol 3-kinase (PI3K) in tumor
    Makino, A.
    Arai, T.
    Temma, T.
    Hirata, M.
    Ono, M.
    Ohmomo, Y.
    Saji, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S450 - S450
  • [38] The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria
    Tsuruta, F
    Masuyama, N
    Gotoh, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) : 14040 - 14047
  • [40] Development of novel PET probes targeting phosphatidylinositol 3-kinase (PI3K) in tumors
    Makino, Akira
    Arai, Takahiro
    Hirata, Masahiko
    Ono, Masahiro
    Ohmomo, Yoshiro
    Saji, Hideo
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2016, 43 (01) : 101 - 107